{"schema_version":"secwatch.filing_event.v1","accession":"0001829126-25-002326","form_type":"8-K","ticker":"ZEOX","cik":"0001557376","company_name":"Zeo ScientifiX, Inc.","filed_at":"2025-04-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.753082+00:00","generated_at":"2026-05-23T23:40:03.587237+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Appoints Ron Borsheim as Chief Sales Officer - Aesthetics effective April 1, 2025","bullets":["Base salary of $225,000 per year; option to purchase 40,000 shares at $2.50/share.","Option vests 50% on first anniversary, 50% on second anniversary; five-year term.","Borsheim has 30+ years experience in aesthetic and regenerative medicine sales, previously at Benev Company, Sofwave Medical, BTL Industries.","Severance: 1/4 month salary per 3 months completed after 90 days if terminated without cause or for good reason.","Position reports to CEO; remote work from Jacksonville Beach, FL with travel to headquarters."],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-25-002326","json":"https://secwatch.observer/filing/0001829126-25-002326.json","markdown":"https://secwatch.observer/filing/0001829126-25-002326.md","text":"https://secwatch.observer/filing/0001829126-25-002326.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1557376/000182912625002326/0001829126-25-002326-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1557376/000182912625002326/zeoscientifix_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T23:40:03.587237+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b40d4c8d8f","claim":"Ron Borsheim was appointed as Chief Sales Officer - Aesthetics at Zeo ScientifiX, Inc..","evidence_excerpt":"Effective April 1, 2025, Ron Borsheim was appointed the Company’s Chief Sales Officer - Aesthetics.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1557376/000182912625002326/0001829126-25-002326-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Sales Officer - Aesthetics"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}